drugset

drugset / Trial / NCT00635973

Open-Label Extension of Other SZ1839 (Iressa) Trials

NCT00635973 ↗

Phase 3 Completed 100 enrolled AstraZeneca

NaSingle-groupOpen-labelTreatment

Summary

A trial to assess patients who have been treated with Iressa in a previous clinical trial and may benefit from continued treatment with Iressa.

Timeline

Start: 2000-02
Primary completion: —
Completion: 2003-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gefitinib	Small molecule	—	—

Indications